Rutgers, The State University Of New Jersey Patent Portfolio Statistics

tip_user1

Rutgers, The State University Of New Jersey

Profile Summary

This article summarizes the perfomance of the assignee in the recent years. The overall statistics for this portfolio help to analyze the areas where the assignee is performing well. The filing trend, perfomance across the tech centers and the perfomance of the recent applications has been mentioned below. All the stats are calculated based on the perfomance in USPTO.

How does the overall patent portfolio of Rutgers, The State University Of New Jersey look like?

Total Applications:	1,484
Granted Patents:	1,021
Grant Index	78.42 %
Abandoned/Rejected Applications:	281 (21.58%)
In-Process Applications:	180
Average Grant Time:	3.0 Years
Average Office Actions:	1.82

Which Technology Area Rutgers, The State University Of New Jersey is filing most patents in? (Last 10 years)

Art Unit	Definition	Total Applications
Opap	Parked GAU	47
1645	Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology	45
1661	Plants	37
1652	Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes	33
1618	Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs	31

How many patents are Rutgers, The State University Of New Jersey filing every year?

Year	Total Applications
2022	0*
2021	43*
2020	55
2019	71
2018	76

*The drop in the number of applications filed in last two years compared to previous years is because applications can take up to 18 months to get published

Recently filed patent applications of Rutgers, The State University Of New Jersey in USPTO?

Publication number: –
Application number: 17/605,750

Abstract:
None

Publication date: –
Applicant: Rutgers, The State University Of New Jersey
Inventors: A Gilleran John

Publication number: US20220002478A1
Application number: 17/475,914

Abstract:
The present invention provides new classes of phenol compounds, including those derived from tyrosol and analogues, useful as monomers for preparation of biocompatible polymers, and biocompatible polymers prepared from these monomeric phenol compounds, including novel biodegradable and/or bioresorbable polymers. These biocompatible polymers or polymer compositions with enhanced bioresorbabilty and processability are useful in a variety of medical applications, such as in medical devices and controlled-release therapeutic formulations. The invention also provides methods for preparing these monomeric phenol compounds and biocompatible polymers.

Publication date: 2022-01-06
Applicant: Rutgers, The State University Of New Jersey
Inventors: Bolikal Durgadas

Publication number: US20210403520A1
Application number: 17/472,760

Abstract:
Inhibitors of interferon regulatory factor 5 (IRF5) nuclear localization and methods of using the inhibitors to treat autoimmune diseases such as systemic lupus erythematosus (SLE) are described.

Publication date: 2021-12-30
Applicant: Rutgers, The State University Of New Jersey
Inventors: Barnes Betsy J

How are Rutgers, The State University Of New Jersey’s applications performing in USPTO?

Application Number	Title	Status	Art Unit	Examiner
17/605,750	Pharmaceutical Compounds And Therapeutic Methods	Docketed New Case – Ready for Examination	OPAP	Central, Docket
17/475,914	Polymeric Biomaterials Derived From Phenolic Monomers And Their Medical Uses	Docketed New Case – Ready for Examination	OPAP	Central, Docket
17/472,760	Cell Penetrating Peptides That Inhibit Irf5 Nuclear Localization	Docketed New Case – Ready for Examination	OPAP	Central, Docket
17/465,011	Vehicular Information Systems And Methods	Docketed New Case – Ready for Examination	OPAP	Central, Docket
17/398,606	In Vivo Radical-Mediated Polymerization For Targeted Delivery Of Trophic Factors	Docketed New Case – Ready for Examination	OPAP	Central, Docket